Shaanxi Kanghui Pharmaceutical (603139) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

CN Stock MarketDetailed Quotes

603139 Shaanxi Kanghui Pharmaceutical

Watchlist

14.24
-0.29-2.00%

Market Closed Jan 16 15:00 CST

1.42BMarket Cap-19.30P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) Surges 28% Yet Its Low P/S Is No Reason For Excitement
Simply Wall StNov 12, 2024 17:19 ET
Kanghui Pharmaceutical's Shaanxi Production Base Renews Production License; Shares Down 6%
MT NewswiresAug 14, 2024 02:30 ET
Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) Might Not Be As Mispriced As It Looks After Plunging 28%
Simply Wall StJun 8, 2024 20:17 ET
Improved Revenues Required Before Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) Stock's 33% Jump Looks Justified
Simply Wall StMar 17, 2024 20:10 ET
Kanghui Pharmaceutical to Earn 151 Million Yuan From Kelavi Buyback
MT NewswiresMar 15, 2024 05:49 ET
Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) Not Doing Enough For Some Investors As Its Shares Slump 26%
Simply Wall StFeb 1, 2024 17:22 ET

Comments

Moomoo AI

Mar 17, 2024 19:35

Despite a rise in share price, Shaanxi Kanghui Pharmaceutical's P/S ratio lags behind others, possibly due to expectations of continued limited growth. A reversal in share price fortunes seems unlikely if trends persist.

Improved Revenues Required Before Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) Stock's 33% Jump Looks Justified

Moomoo AI

Feb 1, 2024 16:48

The company's lower P/S ratio is due to its limited growth rates, which are expected to persist. Investors are paying less for the stock due to these rates. Unless conditions improve, the share price may stay at these levels.